Transdermal delivery of isradipine through excised rabbit skin: Effect of vehicle and drug concentration

Saudi Pharmaceutical Journal

Volumn 11, Issue 1-2, 2003, Pages 46-51

  Al Suwayeh, Saleh A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Ethanol; Isradipine; Polyethylene glycol 400; Propylene glycol; Rabbit skin; Transdermal delivery; Vehicle

Indexed keywords

ALCOHOL; ISRADIPINE; MACROGOL 400; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; MALE; NONHUMAN; RABBIT; SKIN PENETRATION;

EID: 0037696307     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Frishman WH and Michalson MD. Use of calcium antagonists in patients with ischemic heart disease and systemic hypertension. Am J Cardiol 1997; 22: 33-38.
2. Doat M, Hoct JP, Pavin D, Righetti A. Cardiac function improvement 24 hours after isradipine SRO in patients with chronic stable angina: a double-blind randomized study. Acta Cardiol 1996; 51: 155-164.
3. Sandoz Index Pharmaceutical Product Information, International Edition. 1997: 83-92.
4. Mollgaard B and Hoelgaard A. Vehicle Effect on topical drug delivery: II. Concurrent skin transport of drugs and vehicles components. Acta Pharm Suec 1983; 20: 443-450.
5. Sathyan G, Ritschel WA, Hussain A. Transdermal delivery of tarcine: I; Identification of suitable delivery vehicle. Int J Pharm 1995; 114: 75-83.
6. Cross SE, Pugh WJ, Hadgraft J, Roberts MS. Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes. Pharm Res 2001; 18: 999-1005.
7. Gabiga H, Cal K, Janicki S. Effect of penetration enhancers of isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Int J Pharm 2000; 199: 1-6.
8. Ghanem AH, Mahmoud H, Higuchi WI, Rohr UD, Bordia S, Liu P, Fox JL, Good WR. The effects of ethanol on the transport of B-estradiol and other permeants in hairless mouse skin: II. A new quantitative approach. J Controlled Release 1987; 6: 75-83.
9. Berner B, Mazzenga GC, Otte JH, Steffens RJ. Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin. J Pharm Sci 1989; 78: 402-407.
10. Campbell SK, US patent # 437945, 1983.
11. Gale RM and Berggren RG. US patent # 4615699, 1986.
12. Gale RM, Lee ES, Taskocich LT, Yum SI. US patent # 458858, 1986.
13. Poulsen BJ, Coquilla E, Kataz M. Effect of topical vehicle and composition on in vitro release of flucinilone acetonide and its acetate ester. J Pharm Sci 1968; 67: 928-931.
14. Al-Suwayeh SA. Quick, simple and sensitive HPLC method for determination of isradipine in plasma and its application in pharmacokinetic studies. Analytical Letters 2002; 35: 1205-1213.
15. Aguiar AJ and Weiner MA. Percutaneous absorption of chloramphenicol solutions. J Pharm Sci 1969; 58: 210-215.
16. Obata Y, Takayama K, Maitani Y, Machida Y, Nagai T. Effect of ethanol on the permeation of ionized and nonionized diclofenac. Int J Pharm 1993; 89: 191-198.
17. Kurihera-Bergstorm T, Knuston K, DeNoble J, Goates CY. Percutaneous absorption enhancement of ionic molecules by ethanol-water systems in human skin. Pharm Res 1990; 7: 726-766.
18. Megrab AN, William AC, Barry BW. Oestradiol permeation across human skin, silastic and snake skin membranes: the effect of ethanol water co-solvent systems. Int J Pharm 1995; 116: 101-112.
19. Tasi JC, Flynn GL, Weiner N, Ferry JJ. Effect of minoxidil concentration on the deposition of drug and vehicle into the skin. Int J Pharm 1993; 96: 111-117.
20. Bedas B, Schmalfub U, Neubert K. Influence of propylene glycol as cosolvent on mechanism of drug transport from hydrogels. Int J Pharm 1995; 116: 19-30.
21. Kim JH, Cho YJ, Choi HK. Effect of vehicles and pressure sensitive adhesives on the permeation of tarcine across hairless mouse skin. Int J Pharm 2002; 196: 105-113.
22. Okyama H, Ikeda Y, Imamori K, Takayama K, Nagai T. Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm. Int J Pharm 1999; 186: 141-148.
23. Goodman M and Barry BW. Action of penetration enhancers on human stratum cornium as assessed by differential scanning colorimetry. In: Bronaugh RL and Maibach H, eds. Percutaneous absorption: mechanisms-methodology, drug delivery, Dekker, New York, 1989: 567-93.
24. Bouwstra JA, Devries MA, Gooris GS, Bras W, Brussee J, Ponec M. Thermodynamic and structural aspects of the skin barrier. J Controlled Release 1991; 15: 209-220.
25. Sarpotdar PP, Gaskill JL, Giannini RP. Effect of polyethylene glycol 400 on the penetration of drugs through human cadaver skin in vitro. J Pharm Sci 1986; 75(1): 26-28.
26. Tojo K, Chiang CC, Chien YW. Influence of donor solution upon skin permeation of drugs. J Chem Eng Japan 1986; 19: 153-155.
27. Watkinson AC, Joubin H, Green DM, Brian KR, Hadgraft J. The influence of vehicle on permeation from saturated solutions. Int J Pharm 1995; 121: 27-36.
28. Wotten P, Mollgaard B, Hadgraft J, Hoelgaard A. Vehicle effect on topical drug delivery. III. Effect of azone on cutaneous permeation of metronidazole and propylene glycol. Int J Pharm 1985; 24: 19-26.
29. Niazy EM, Molokhia A M, El-Gorashi AS. Effect of vehicle and drug concentration on transdermal delivery of dihydroergotamine using excised animal skin. Drug Dev Ind Pharm 1990; 16: 1697-1715.
30. Wester RC and Maibach HI. Relationship of topical dose and percutaneous absorption in Rhesus monkey and man. J Invest Dermatol 1976; 67: 518-520.
31. Scheuplein RJ and Ross LW. Mechanism of percutaneous absorption, V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 1974; 62: 353-360.